EVANS HANDEL 4
4 · ALLERGAN INC · Filed Jan 5, 2006
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
EVANS HANDEL
Director
Transactions
- Award
Phantom Stock Units
2006-01-03$109.12/sh+91.64$10,000→ 28,313.84 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2006-01-03$109.12/sh+22.91$2,500→ 28,336.75 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-12-12$109.94/sh+25.65$2,820→ 28,222.2 total→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Converts to common stock on a 1-for-1 basis.
- [F2]Phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan, exempt transaction under Rule 16a-11.
- [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
- [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.